Community/Retail

The launch of adalimumab biosimilars are expected to affect spending in the immunology space.

Stakeholders need to convene honest, actionable discussions about the challenges and the safeguards needed to address appropriate use of artificial intelligence in health care.

Study investigators suggest that there is a higher prevalence of pain and treatment needs in this small population.

Pharmacists will have the opportunity to use their knowledge of biosimilars to reinforce their benefits, safety, and efficacy.

Although not a traditional at-risk group for severe respiratory syncytial virus complications, pregnant patients should be aware of the possibility of infection and be educated on proper prevention procedures.

A panel released recommendations in accordance with decades of a changing landscape in acetaminophen poisoning and due to an absence of agreed upon guidelines in the space.

Session at NACDS Total Store Expo discusses how pharmacies can leverage their accessibility to decrease diet-related diseases through health and wellness.

Expert weighs in on the growth of specialty drug spending, particularly with drugs in immunology, neurology, and weight loss.

Study authors note that additional research is necessary to confirm findings and identify biological pathways of associations between sweetened beverages and diseases of the liver.

Previous studies were not able to establish whether the risk of developing myasthenia gravis was caused by or led to vitamin D deficiency.

Research shows a substantial difference between overall deaths of men and women at 43% and 28.2%, respectively, from cardiovascular disease associated with particulate matter.

Because the generic name of both the timolol once-daily and twice-daily formulations is the same, pharmacies should only carry 1 formulation.

Session at NACDS Total Store Expo discusses how to address shortcomings in women’s health areas in the health and wellness industry.

Pharmacists can improve patient access to both healthful foods and necessary medicines as a continuum of care in underserved communities.

Session at NACDS Total Store Expo discusses minor changes that retail companies can make to mesh artificial intelligence into their work to increase sales, improve margins, and lower costs.

Entrepreneurs and healthcare retailers can support pharmacists by digitizing the recommendation model and closing the diagnostic gap.

Educator and pharmacy advocate encourages pharmacists to work together to improve the scope of the profession and patient access to services.

Advancements in the development of amyloid-targeting monoclonal antibodies show promise for treating Alzheimer disease, but there have been concerns around cost, adverse reactions, and inequity of care for marginalized patients.

New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.

The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.

Although SB5 is an effective treatment for plaque psoriasis, it is recommended that patients consider the potential risks and adverse effects.

Pharmacy technicians are stepping up to assume expanded responsibilities that contribute to pharmacy management and patient safety.

Despite the low uptake of healthy lifestyle behaviors to achieve 5% weight loss or greater, the probability of weight loss increased among individuals with higher initial BMI.

The program would aim to incentivize competition in small molecule generics markets, which currently have limited competition.

Gretchen Garofoli, PharmD, an associate professor at the West Virginia School of Pharmacy, discusses the current recommendations for COVID-19, respiratory syncytial virus (RSV), and influenza vaccines and vaccine hesitancy.

Results of phase 3 trials could lead to the approval of remibrutinib to provide more effective and controlled treatment of chronic spontaneous urticaria than H1-antihistamines.

Approximately 57% of individuals who were shown a flowchart of the FDA vaccine approval process were very or somewhat likely to recommend a respiratory syncytial virus vaccine to a pregnant family member or friend compared to only 40% of those who were not shown the process.

Policy efforts must be put in place to support HCV treatment for all individuals to reduce the disparities in direct-acting antiviral treatment.

A variety of comorbid mood disorders often accompany this condition, including OCD and PTSD.

No major changes were found in overdose behaviors among individuals who received take-home naloxone.